RIL
AGIO icon

Rothschild Investment LLC’s Agios Pharmaceuticals AGIO Stock Holding History

Rothschild Investment LLC’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9K Buy
402
+362
+905% +$11K ﹤0.01% 1679
2026
Q1 		$1.35K Buy
40
+35
+700% +$992 ﹤0.01% 2737
2025
Q4 		$136 Sell
5
-70
-93% -$2.46K ﹤0.01% 3169
2025
Q3 		$3.01K Sell
75
-15
-17% -$564 ﹤0.01% 1973
2025
Q2 		$2.99K Sell
90
-20
-18% -$606 ﹤0.01% 1790
2025
Q1 		$3.22K Buy
110
+85
+340% +$2.82K ﹤0.01% 1643
2024
Q4 		$822 Sell
25
-30
-55% -$1.41K ﹤0.01% 2333
2024
Q3 		$2.44K Buy
55
+35
+175% +$1.59K ﹤0.01% 1624
2024
Q2 		$862 Buy
20
+15
+300% +$541 ﹤0.01% 1736
2024
Q1 		$146 Buy
+5
New +$134 ﹤0.01% 1930

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Rothschild Investment LLC's AGIO Position: Q2 2026 in Review

Rothschild Investment LLC increased its Agios Pharmaceuticals (AGIO) stake by 905% in Q2 2026, buying an estimated $11K and bringing the position to 402 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1679.

Rothschild Investment LLC first reported a position in AGIO in Q1 2024 and has held it in 10 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Rothschild Investment LLC held 402 shares of Agios Pharmaceuticals worth $14.9K as of Q2 2026.
  • Rothschild Investment LLC bought 362 Agios Pharmaceuticals shares in Q2 2026, an estimated $11K.
  • Agios Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1679 holding.
  • Rothschild Investment LLC first reported a position in Agios Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.